Shares of iCo Therapeutics Inc (OTCMKTS:ICOTF) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.06 and traded as low as $0.11. iCo Therapeutics shares last traded at $0.11, with a volume of 5,000 shares.
The stock’s 50-day moving average is $0.07 and its 200-day moving average is $0.06.
iCo Therapeutics Company Profile (OTCMKTS:ICOTF)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
Receive News & Ratings for iCo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.